At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 23 Sep 1997 No-Development-Reported for Hypertension in USA (PO)
- 24 Oct 1994 Preclinical development for Hypertension in USA (PO)